Impact of cranial and axillary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis

被引:42
|
作者
Czihal, Michael [1 ]
Piller, Anne [1 ]
Schroettle, Angelika [1 ]
Kuhlencordt, Peter [1 ]
Bernau, Christoph [3 ,4 ]
Schulze-Koops, Hendrik [2 ]
Hoffmann, Ulrich [1 ]
机构
[1] Munich Univ Hosp, Div Vasc Med, D-80336 Munich, Germany
[2] Munich Univ Hosp, Div Rheumatol & Clin Immunol, D-80336 Munich, Germany
[3] Munich Univ Hosp, Med Clin & Policlin 4, D-80336 Munich, Germany
[4] Munich Univ Hosp, Dept Med Informat Biometry & Epidemiol, D-80336 Munich, Germany
关键词
PLACEBO-CONTROLLED TRIAL; LARGE-VESSEL INVOLVEMENT; DOUBLE-BLIND; METHOTREXATE; THERAPY; ULTRASONOGRAPHY; FEMOROPOPLITEAL; INTERLEUKIN-6; DURATION;
D O I
10.1016/j.jvs.2014.12.045
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Color duplex sonography (CDS) today is broadly used in the diagnostic workup of patients with suspected cranial or extracranial giant cell arteritis (GCA). This study aimed to determine the prognostic impact of the disease pattern assessed by CDS on the treatment response in GCA. Methods: This was a retrospective, longitudinal follow-up study of 43 patients who were diagnosed with GCA at our institution between 2002 and 2010. All patients underwent CDS of the temporal and subclavian/axillary arteries at baseline and were observed for at least 6 months. Vasculitis was sonographically characterized by a circumferential, hypoechogenic wall thickening. According to the CDS findings, patients were categorized into patients with involvement of the subclavian/axillary arteries only (group A1, n = 17), patients with involvement of both the subclavian/axillary arteries and the temporal arteries (group A2, n = 9), and patients with isolated cranial GCA (group B, n = 17). Data on recurrences, corticosteroid doses, and steroid-sparing agents were extracted from the medical records. Treatment response over time was analyzed by Kaplan-Meier curves with log-rank testing. Results: The mean follow-up time was 25.4 months and did not differ between groups (P = .4). Patients in group A1 were significantly younger than patients in groups A2 and B (P < .01). The interval between symptom onset and diagnosis was significantly longer in groups A1 and A2 compared with group B (P < .01). The number of recurrences per month was significantly higher in group A2 compared with group A1 and group B (A1, 0.07; A2, 0.13; B, 0.03; P < .01). Whereas there were no significant differences in the mean time until a daily prednisolone dose <10 mg was reached, patients in group A2 more frequently required steroid-sparing agents (A1, 24%; A2, 56%; B, 24%; P = .04). Conclusions: Extensive vascular involvement of both the temporal and subclavian/axillary arteries, as depicted by CDS, may be associated with a poor treatment response in GCA.
引用
收藏
页码:1285 / 1291
页数:7
相关论文
共 50 条
  • [31] Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study
    Germano, Giuseppe
    Muratore, Francesco
    Cimino, Luca
    Lo Gullo, Alberto
    Possemato, Niccolo
    Macchioni, Pierluigi
    Cavazza, Alberto
    Pipitone, Nicolo
    Boiardi, Luigi
    Salvarani, Carlo
    RHEUMATOLOGY, 2015, 54 (03) : 400 - 404
  • [32] Giant cell arteritis presenting with bilateral vertebral and axillary artery occlusions
    Akdal, G.
    Thurtell, M. J.
    Halmagyi, G. M.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (09) : 741 - U15
  • [33] Comparison of Histopathological Findings with Duplex Sonography of the Temporal Arteries in Suspected Giant Cell Arteritis
    Pfenninger, L.
    Horst, A.
    Stuckmann, G.
    Flury, R.
    Stuermer, J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (04) : 369 - 373
  • [34] Color Doppler sonography of the temporal arteries in giant cell arteritis and polymyalgia rheumatica
    Lauwerys, BR
    Puttemans, T
    Houssiau, FA
    Devogelaer, JP
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (08) : 1570 - 1574
  • [35] Myocardial infarction and coronary artery involvement in giant cell arteritis
    Freddo, T
    Price, M
    Kase, C
    Goldstein, MP
    OPTOMETRY AND VISION SCIENCE, 1999, 76 (01) : 14 - 18
  • [36] Prognosis of severe vertebral artery involvement in giant cell arteritis
    Schlaeger, A.
    Draeger, S.
    Vaith, P.
    Reinhard, M.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 142 - 142
  • [37] Ultrasound to detect involvement of vertebral artery in giant cell arteritis
    Gehlen, M.
    Schaefer, N.
    Schwarz-Eywill, M.
    Maier, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : S169 - S170
  • [38] Maxillary artery involvement in giant cell arteritis demonstrated by ultrasonography
    Chen-Xu, Michael
    Coath, Fiona L.
    Ducker, Georgina
    Fordham, Sarah
    Mukhtyar, Chetan B.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2021, 51 (04): : 366 - 368
  • [39] A Rare Case of Giant Cell Arteritis With Coronary Artery Involvement
    Nyange, Christabel E.
    Toole, Joseph
    Chang, William
    Snyder, Matthew
    Fisher, Perry
    CIRCULATION, 2020, 142
  • [40] LARGE ARTERY INVOLVEMENT IN GIANT-CELL (TEMPORAL) ARTERITIS
    KLEIN, RG
    HUNDER, GG
    STANSON, AW
    SHEPS, SG
    ANNALS OF INTERNAL MEDICINE, 1975, 83 (06) : 806 - 812